Jeil Pharma Holdings Inc (002620.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 128.42B |
| Enterprise Value | 239.6B |
| P/E Ratio | 8.06 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 0.18 |
| Price/Book Ratio | 0.34 |
| Enterprise/Revenue | 0.36 |
| Enterprise/EBITDA | -8.26 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.02 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 657.61B |
| Revenue/Share | 40,104.42 |
| Gross Profit | 226.27B |
| EBITDA | 30.02B |
| Net Income | 14.64B |
| Diluted EPS | 953.37 |
Balance Sheet
| Total Cash | 83.36B |
| Total Cash/Share | 5,430.42 |
| Total Debt | 168.67B |
| Total Debt/Equity | 0.53 |
| Current Ratio | 1.22 |
| Book Value Per Share | 30,950.39 |
Price History
| 52-Week Change | -16.75 |
| 52-Week High | 9,850 |
| 52-Week Low | 6,050 |
| Moving Average 50 Days | 7,072.6 |
| Moving Average 200 Days | 8,006.45 |
Statistics
| Average Volume | 13,190 |
| Shares Outstanding | 15.35M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 70 |
| Trailing Annual Dividend Yield | 0.99 |
| Payout Ratio | 0.01 |
| Last Split Factor | 73:250 |
| Last Split Date | July 17, 2017 |
AD
